Skip to main content
Log in

Cancer prediction

Participating journal: Biology Direct
The identification of individual or clusters of predictive genetic alterations might help in defining the outcome of cancer treatment, allowing for the stratification of patients into distinct cohorts for selective therapeutic protocols. This approach, currently developed with the aid of Artificial Intelligence and Machine Learning, might result in maximising the therapeutic success and minimizing harmful effects in cancer patients. Here, we showcase some recent papers which describe distinct aspects of precision oncology, the ability to stratify patients with distinct prognostic features and therapeutic requirements, as well as its liaison with the current complexity of the underlying molecular mechanisms.

Participating journal

Submit your manuscript to this collection through the participating journal.

Journal

Biology Direct

As an author driven, open peer-review journal, Biology Direct provides authors and readers with a transparent alternative to the traditional model of peer review.

Editors

  • Gerry Melino

    Cambridge University, England Gerry Melino is Head of the Apoptosis & Cancer Laboratory, Medical Research Council Toxicology Unit, UK; and Professor of Molecular Biology (Medicine), University of Rome "Tor Vergata".

Articles

Showing 1-5 of 5 articles

Navigation